Drugs & Side Effects | Cancer Drugs

Fosamax News

Osteoporosis Medication Makers Battle in Court

RSS News Feeds
Drugs & Pharmacuticals
Osteonecrosis of the Jaw (ONJ)
Fosamax
 All RSS Feeds

At a glance:

A lawsuit is under way in New York requesting that Hoffman-LaRoche alter some of its claims regarding its osteoporosis drug Boniva. 
 
Proctor & Gamble, maker of rival drug Actonel, says that Boniva only reduces risk of spinal fracture while its drug and Merck's Fosamax affect other common fracture sites. 
 
Hoffman-LaRoche insists its claims are accurate and that the other companies are just trying to regain market share with their claims.

Bone Drug Goes to Court

The Ledger - 6/3/2006 6:17 AM

NEW YORK -- Two giant drug companies are waging a battle in Manhattan federal court over the market for drugs aimed at protecting the brittle bones of older women -- a multibillion-dollar business expected to rapidly expand in the coming years.
 
Procter & Gamble Pharmaceuticals Inc. has asked a judge to force Hoffman-LaRoche Inc. to withdraw some of its advertising and stop making some of its claims about its new osteoporosis drug, Boniva
 
· Read The Full Fosamax Article From The Ledger -->

· Read All Fosamax (Alendronate) News Stories -->

Comments On Fosamax News Articles:


No Current Comments
Posted by Admin on 3/20/2006

There are no current comments. Why not post one?

Leave a Comment:

Once you click the 'Save Comment' button, you will receive a verification email from our website. Be sure to change any spam settings to allow webmaster@lawsuitsearch.com as a trusted sender.
 
If you are already a member, you can Sign In Here.
 
You can create your own FREE user account that you can use to participate in our message boards, blogs, newsletters and other community activities such as this one. To get your FREE user account, click here.

Email Address:

Your Name:

Message Title:

Message: